Home Overview Press Room Blog Publications For Students about us
Search

Medical Gene Transfer : Displaying 86-95 of 348


Cautious approach warranted for new gene-editing techniqueby Paul KnoepflerThe Sacramento BeeFebruary 13th, 2016We urgently need a moratorium on using CRISPR technology on future people, and a full public debate while we learn more about its potential positive and negative effects.
This CRISPR Momentby Françoise Baylis and Janet RossantThe WalrusFebruary 12th, 2016Editing human DNA the way we edit text—are we ready?
A Nobel Laureate's 'Unsettling Note' From California's Human Gene Editing Conference[cites CGS' Marcy Darnovsky]by David JensenCalifornia Stem Cell ReportFebruary 12th, 2016The Center for Genetics and Society weighs in on the possibility that California's stem cell agency will fund germline gene editing research.
California stem cell agency may fund tests to edit genes in human embryos[cites CGS' Marcy Darnovsky]by Melody PetersenLos Angeles TimesFebruary 12th, 2016The state's stem cell institute is reviewing its ethics guidelines to determine whether they are strong enough to safely allow studies in which scientists would attempt to edit the genes of embryos.
STAT-Harvard poll: Americans say no to ‘designer babies’by Sharon BegleySTATFebruary 11th, 2016Most Americans oppose using powerful new technology to "alter the genes of unborn babies," according to a new poll, even to prevent serious inherited diseases.
California’s Stem Cell Agency Considers “Editing” Human Embryosby Marcy Darnovsky Biopolitical Times February 9th, 2016Three takeaway points from CIRM’s recent meeting on human gene editing.
We Are This Close to "Designer Babies"[cites CGS' Marcy Darnovsky]by Nina Liss-SchultzMother JonesFebruary 8th, 2016Issues to consider in light of the UK's approval of using CRISPR gene editing on human embryos for research.
Stem cell agency to begin review of human genetic changes by David JensenCapitol WeeklyFebruary 5th, 2016California’s stem cell agency has embarked on what is likely to be an exhaustive review of its rules for research involving genetic alteration of human embryos.
The billion-dollar CRISPR patent battle: A case of big money shaping scienceby Michael HiltzikLos Angeles TimesFebruary 5th, 2016"The real question is whether the future of the technology will be guided by the need to learn more, or the opportunity to earn more."
The Embarrassing, Destructive Fight over Biotech's Big Breakthrough by Stephen S. HallScientific AmericanFebruary 4th, 2016The gene-editing technology known as CRISPR has spawned an increasingly unseemly brawl over who will reap the rewards.
Displaying 86-95 of 348  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760